{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:59:36Z","timestamp":1754481576429},"reference-count":30,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v104.40627","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T11:26:28Z","timestamp":1725881188000},"page":"adv40627","source":"Crossref","is-referenced-by-count":1,"title":["Anti-p200 Pemphigoid Mimicking Acquired Reactive Perforating Collagenosis"],"prefix":"10.2340","volume":"104","author":[{"given":"Janik","family":"Flei\u00dfner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Ickrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kerstan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"72165","doi-asserted-by":"crossref","unstructured":"Chen KR, Shimizu S, Miyakawa S, Ishiko A, Shimizu H, Hashimoto T. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen. Br J Dermatol 1996; 134: 340-346.","DOI":"10.1111\/j.1365-2133.1996.tb07625.x"},{"key":"72166","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2133.1996.tb07625.x","DOI":"10.1111\/j.1365-2133.1996.tb07625.x"},{"key":"72167","doi-asserted-by":"crossref","unstructured":"van Beek N, Weidinger A, Schneider SW, Kleinheinz A, Glaser R, Holtsche MM, et al. Incidence of pemphigoid diseases in Northern Germany in 2016: first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases. J Eur Acad Dermatol Venereol 2021; 35: 1197-1202.","DOI":"10.1111\/jdv.17107"},{"key":"72168","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17107","DOI":"10.1111\/jdv.17107"},{"key":"72169","doi-asserted-by":"crossref","unstructured":"Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996; 106: 465-470.","DOI":"10.1111\/1523-1747.ep12343631"},{"key":"72170","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1523-1747.ep12343631","DOI":"10.1111\/1523-1747.ep12343631"},{"key":"72171","doi-asserted-by":"crossref","unstructured":"Kridin K, Ahmed AR. Anti-p200 pemphigoid: a systematic review. Front Immunol 2019; 10: 2466.","DOI":"10.3389\/fimmu.2019.02466"},{"key":"72172","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fimmu.2019.02466","DOI":"10.3389\/fimmu.2019.02466"},{"key":"72173","doi-asserted-by":"crossref","unstructured":"Goletz S, Pigors M, Lari TR, Hammers CM, Wang Y, Emtenani S, et al. Laminin beta4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid. J Am Acad Dermatol 2024; 90: 790-797.","DOI":"10.1016\/j.jaad.2023.11.014"},{"key":"72174","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2023.11.014","DOI":"10.1016\/j.jaad.2023.11.014"},{"key":"72175","doi-asserted-by":"crossref","unstructured":"Goletz S, Probst C, Komorowski L, Radzimski C, Mindorf S, Holtsche MM, et al. Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin beta4 subunit. Br J Dermatol 2024; 191: 140-141.","DOI":"10.1093\/bjd\/ljae136"},{"key":"72176","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/bjd\/ljae136","DOI":"10.1093\/bjd\/ljae136"},{"key":"72177","doi-asserted-by":"crossref","unstructured":"Goletz S, Hashimoto T, Zillikens D, Schmidt E. Anti-p200 pemphigoid. J Am Acad Dermatol 2014; 71: 185-191.","DOI":"10.1016\/j.jaad.2014.02.036"},{"key":"72178","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2014.02.036","DOI":"10.1016\/j.jaad.2014.02.036"},{"key":"72179","doi-asserted-by":"crossref","unstructured":"Semeria L, Lamiaux M, Quinchon JF, Modiano P. Anti-p200 pemphigoid mimicking erythema multiforme. JAAD Case Rep 2022; 21: 157-159.","DOI":"10.1016\/j.jdcr.2022.01.011"},{"key":"72180","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.01.011","DOI":"10.1016\/j.jdcr.2022.01.011"},{"key":"72181","doi-asserted-by":"crossref","unstructured":"Wagner G, Sachse MM. Acquired reactive perforating dermatosis. J Dtsch Dermatol Ges 2013; 11: 723-729, 723-730.","DOI":"10.1111\/ddg.12131"},{"key":"72182","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ddg.12131","DOI":"10.1111\/ddg.12131"},{"key":"72183","doi-asserted-by":"crossref","unstructured":"Kakehi Y, Miyagawa F, Ogawa K, Hashimoto T, Asada H. Case of anti-laminin gamma1 pemphigoid associated with ulcerative colitis and acquired perforating dermatosis. J Dermatol 2021; 48: e35-e36.","DOI":"10.1111\/1346-8138.15624"},{"key":"72184","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1346-8138.15624","DOI":"10.1111\/1346-8138.15624"},{"key":"72185","doi-asserted-by":"crossref","unstructured":"Maki N, Nishie W, Takazawa M, Kakurai M, Yamada T, Umemoto N, et al. Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis. J Dermatol 2018; 45: 600-602.","DOI":"10.1111\/1346-8138.14254"},{"key":"72186","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1346-8138.14254","DOI":"10.1111\/1346-8138.14254"},{"key":"72187","doi-asserted-by":"crossref","unstructured":"Nomura H, Mukai M, Niimi Y, Egami S, Yokoyama T, Sugiura M, et al. Coexistence of acquired perforating dermatosis and bullous pemphigoid: three cases. Eur J Dermatol 2017; 27: 192-193.","DOI":"10.1684\/ejd.2016.2944"},{"key":"72188","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1684\/ejd.2016.2944","DOI":"10.1684\/ejd.2016.2944"},{"key":"72189","doi-asserted-by":"crossref","unstructured":"Schauer F, Kern JS, Virtic O, Technau-Hafsi K, Meiss F, Thoma K, et al. A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid. Br J Dermatol 2019; 180: 231-232.","DOI":"10.1111\/bjd.17146"},{"key":"72190","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.17146","DOI":"10.1111\/bjd.17146"},{"key":"72191","doi-asserted-by":"crossref","unstructured":"Tani S, Ishii N, Hashimoto T, Tsujioka K. Bullous pemphigoid arising in a patient with acquired perforating dermatosis. Clin Exp Dermatol 2017; 42: 406-409.","DOI":"10.1111\/ced.13080"},{"key":"72192","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ced.13080","DOI":"10.1111\/ced.13080"},{"key":"72193","doi-asserted-by":"crossref","unstructured":"Tasanen K, Varpuluoma O, Nishie W. Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. Front Immunol 2019; 10: 1238.","DOI":"10.3389\/fimmu.2019.01238"},{"key":"72194","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fimmu.2019.01238","DOI":"10.3389\/fimmu.2019.01238"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/40627\/47617","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/40627\/47617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T11:26:47Z","timestamp":1725881207000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/40627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2340\/actadv.v104.40627","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,9]]}}}